Skip to content

Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)

Subdural Hematoma

EMMA-Can is a prospective cohort study to assess the safety and effectiveness of MMA-embolization for the treatment of CSDH.

Hypothesis- EMMA reduces the recurrence rate of SDH with or without concomitant surgical evacuation.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* All patients with subdural hematoma coming to the emergency room or to neurosurgical outpatient clinic

Exclusion Criteria:

* When informed consent is not possible
* Known allergy to liquid embolic agent

Study Location

Health Sciences centre
Health Sciences centre
Winnipeg MB, Manitoba
Canada

Contact Study Team

Primary Contact

Jai Shankar, MD FRCPC

[email protected]
431 373 4164
Backup Contact

Susan Alcock

[email protected]
204 789 3996
Study Sponsored By
University of Manitoba
Participants Required
More Information
Study ID: NCT04923984